Keith Tode is a global executive bringing over 25 years of experience in strategic leadership roles ranging from start-ups to Fortune 100 companies. With previous experience at such companies as PAREXEL International, Thomson Reuters Life Sciences (now Clarivate Analytics) and MCRA, he has worked across the development lifecycle for pharmaceutical, biotechnology and medical device companies, supporting clinical trials, regulatory submissions, RWE and HEOR, and quality and compliance. Tode is a recognized thought leader in promoting clinical trial diversity and currently serves on the Board of Directors of Pan-African Clinical Trials (PACT) headquartered in London.
Those of us involved in clinical research thought we’d have a few years to adapt to new technologies and the move toward decentralized and virtual trials. Then COVID hit and the evolution accelerated significantly. Unfortunately, as many organizations struggle to keep up, some are at risk of being left behind. If you’re ready to evolve, instead…